Name: Sagimet Biosciences Inc. (SGMT) Balance Sheet
Creator: FinSpry

Sagimet Biosciences Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Sagimet Biosciences Inc. (SGMT) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	75.84	94.90	0.16	56.73	68.70
Short-Term Investments	75.41	19.76	32.19	0.00	0.00
Cash & Short-Term Investments	151.25	94.90	32.35	56.73	68.70
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.16	1.78	0.41	0.42	0.00
Total Current Assets	152.77	96.65	32.79	58.66	68.74
Non-Current Assets
Property, Plant & Equipment (Net)	0.08	0.07	0.21	0.34	0.19
Long-Term Investments	7.41	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.03	0.03	0.03
Total Non-Current Assets	7.49	0.07	0.24	0.37	0.00
Total Assets	160.26	96.72	33.03	59.03	68.96
Current Liabilities
Accounts Payable	1.43	5.59	1.13	0.76	0.51
Short-Term Debt	0.16	0.00	0.00	0.00	0.00
Accrued Liabilities	2.95	4.85	3.96	1.32	1.01
Other Current Liabilities	0.01	1.11	0.06	0.24	0.24
Total Current Liabilities	4.45	5.65	5.28	2.44	1.91
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.08	0.22	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00
Total Non-Current Liabilities	0.00	0.00	214.70	214.85	0.00
Total Liabilities	4.45	5.65	5.36	2.66	1.98
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-295.31	-249.71	-221.87	-191.37	-166.93
Accumulated Other Comprehensive Income	0.23	0.03	-0.08	0.00	0.00
Additional Paid-in Capital	450.88	340.78	35.00	33.11	0.00
Shares Outstanding	32.20	22.90	22.17	22.17	0.00
Total Stockholders' Equity	155.81	91.06	27.67	56.37	66.98
Total Liabilities & Equity	160.26	96.72	33.03	59.03	0.00